Canada markets close in 3 hours 22 minutes

CBD Unlimited, Inc. (EDXC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1525-0.0070 (-4.39%)
As of 12:09PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.1595
Open0.1595
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1460 - 0.1595
52 Week Range0.0310 - 0.2849
Volume296,991
Avg. Volume1,484,328
Market Cap30.775M
Beta (5Y Monthly)2.36
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Endexx Contracts Beauty Barrage to Drive New Cosmetic Brand
    GlobeNewswire

    Endexx Contracts Beauty Barrage to Drive New Cosmetic Brand

    Cave Creek, AZ, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation, (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative Hemp-Derived topical and cosmetic product, is pleased to announce it has contracted with Beauty Strategy Group, a market leader in cosmetic and skin care brand representation. Beauty Strategy Group is 100% owned, controlled, and operated by women company. Beauty Strategy Group and Beauty Barrage represents leading brands: L'Oréal, PerriconeMD, The Proactiv Company, Unilever, Dermaflash and many others. They support brand success and pull through in stores like Sephora, Ulta and leading premium retail chains: Bloomingdales, Neiman Marcus, and Nordstrom. Beauty Barrage provides training & education for retail associates, in-store event creation and execution, pop-up shops and sales support – all field tactics that are crucial to helping a brand succeed at retail. The BSG team includes over 300 beauty professionals servicing over 3,000 doors in the U.S. and Canada. This elite team of beauty advisors, trainers, and managers treats your brand as if it were “their” own. Sonia Summers, CEO and Founder of Beauty Strategy Group, stated, "We are happy to work with Endexx Corp to bring innovative products to market helping to drive incremental growth to our retail partners. We are very excited to partner with a trusted brand, committed to education and product excellence. We look forward to working with Todd and his team on bringing best-in-class product in men's grooming to market in these channels.” CEO Endexx, Todd Davis, commented, “The BSG team brings the professional ‘Human Touch’ needed to successfully place and sell through product in the Mass Retail space.” Davis added, “Sonia Summers is an inspirational business leader and provides 20 years of expertise we need to support our cosmetic and topical CBD Products.” https://www.beautystrategygroup.com/ https://www.beautybarrage.com/ About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, please contact: Endexx Corporation Todd Davis, Chairman and CEO endexx@endexx.com 480-595-6900

  • Endexx Files Amended Form 10 Including Fiscal 2020 PCAOB Audited Financials
    GlobeNewswire

    Endexx Files Amended Form 10 Including Fiscal 2020 PCAOB Audited Financials

    CAVE CREEK, AZ, April 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based skin care and nutritional products, today announced an update that it has publicly filed its fiscal 2020 PCAOB audited financials with the amended Registration Statement on Form 10 with the Securities and Exchange Commission (SEC). This is a voluntary filing that is subject to SEC review. If the Registration Statement becomes effective, it would designate Endexx as an SEC reporting company and register its shares pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended. Additionally, if the Registration Statement becomes effective, private and accredited investors who purchased or purchase shares in the Company through private placement would have adjusted holding periods for registration, as the statutory holding period of private placement shares would be reduced, under Rule 144 of the Securities Act of 1933, as amended (the Securities Act). Endexx currently publishes quarterly and annual reports as well as PCAOB audited financial statements, and is in compliance with OTC Markets Alternative Reporting Standard (ARS). Should the Registration Statement become effective, Endexx would file these reports and financial statements as 10-Qs and 10-Ks with the SEC, along with current reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. See Filing: https://sec.report/Document/0001493152-21-008293/?fbclid=IwAR1-TK6-2fkumN7E52pumS8VMp2jhjPi-yssHq0yAN30Z4QrP4L1qtfFgVA About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact:Endexx CorporationTodd DavisChairman & CEOEndexx@endexx.com 480-595-6900

  • Endexx Files Form 10 Registration Statement for SEC Review
    GlobeNewswire

    Endexx Files Form 10 Registration Statement for SEC Review

    CAVE CREEK, AZ, March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced that it has publicly filed its Registration Statement on Form 10 with the Securities and Exchange Commission (SEC). This is a voluntary filing that is subject to SEC review. If the Registration Statement becomes effective, it would designate Endexx as an SEC reporting company and register the class of its shares of common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Additionally, if the Registration Statement become effective, investors, who purchased or purchase shares of the Company’s common stock through private placements, would be permitted to resell their shares into the public markets pursuant to the exemption from registration under Rule 144 of the Securities Act of 1933, as amended, subject to compliance with the Rule’s provisions. Endexx currently publishes quarterly and annual reports, which include its financial statements, and is in compliance with the OTC Markets Group’s Alternative Reporting Standards. If the Registration Statement becomes effective, Endexx would file these reports and financial statements in the form of 10-Qs and 10-Ks with the SEC, along with Current Reports on Form 8-K, in addition to complying with its other obligations under the Exchange Act. See Filing: https://sec.report/Document/0001493152-21-005346/ About Endexx Corporation Endexx Corporation, through its operating subsidiary CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab-work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the OTC Markets Group’s and the Company’s Form 10 filed with the SEC. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEO Endexx@endexx.com 480-595-6900